BIT Life Sciences’ 3rd Annual World
Vaccines Congress-2011
(WCV-2011)
Theme: The Future of Global Vaccines
Time: March 23 - 25, 2011
Venue: Beijing, China
|
Scientific Program
|
|
Group Photo
Time: 08:30 Place: E1 Entrance, CNCC
|
|
Opening Ceremony & Keynote Forum
Place: Room No. 311B, 3F, CNCC
|
| Moderator |
Dr. Jonathan J Liu, Director of R& D, Vaccine Development, MedImmune, USA
|
|
09:15-09:45
|
Title: Opportunities and Challenges in Vaccine R&D with a Focus on Emerging Markets
Dr. Michel De Wilde, Senior Vice President of Research & Development, Sanofi Pasteur, Belgium
|
|
09:45-10:15
|
Title: Opportunities and Challenges for New Vaccines
Dr. John W. Shiver, Vice President, Worldwide Basic Research Franchise Head, Vaccines. Merck & Co., Inc. USA
|
|
10:15-10:45
|
Title: Commercialization Strategies for Vaccines in the Emerging Markets
Dr. Rahul Singhvi, CEO & President, Novavax Inc., USA
|
|
10:45-11:15
|
Title: How Businesses Can Deepen Their Impact on Global Health
Dr. John E. Tedstrom, President & CEO, Global Business Coalition on HIV/AIDS, Tuberculosis & Malaria (GBC), USA
|
|
11:15-11:45
|
Title:Therapeutic Vaccine-revisited: Clinical Trials of Therapeutic Vaccine (YIC) for Chronic Hepatitis B Patients
Dr. Yumei Wen, Academician, Chinese Academy of Engineering, China
|
11:45-12:15
 |
Title: Accelerating Your Vaccine Discovery and Development
Dr. Yang Wang, Vice President, Sino Biological, Inc., China |
|
18:30-20:30
|
Welcome Banquet
|
|
Scientific Program
|
|
Opening Ceremony & Keynote Forum
-The Future of Global Vaccines
|
|
Chapter 1: Global Immunization Plans and Alliances
-Stop Fatal Diseases and Take Actions
|
|
Chapter 2: Breaking Research and Tech Development in Modern Vaccinology
-New Thoughts, New Wave, New Methods and New Gateway for Success
|
|
Chapter 3: Human Diseases and Vaccines
-From Research to Market on Both Infectious and Non-Infectious Diseases
|
|
Chapter 4: Livestock/Veterinary/ Aquaculture Vaccines
-Maintain a Healthier Animal Kingdom by Immunization
|
|
Chapter 5: Vectors, Adjuvants, and Vaccine Delivery Technology
-Smart Assistants to the Effective Vaccinations
|
|
Chapter 6: Animal Models and Clinical Trials
-Safety and Efficacy Security Using Right Models and Assessments
|
|
Chapter 7: Vaccine Bioprocess, Production and Manufacturing
-Meet the Demand on Safe and Productive Green Bio-Industry
|
|
Chapter 8: Public Health, Economics, Safety/Ethic and Policy of Vaccination
-Understanding the Legislative, Social, Ethic and Public Health Systems
|
|
Chapter 9:Special Symposium: Young Investigator Research
-Hope, Faith, Followers and the Future
|
|
